Clinical and Immunologic Predictors of Death After an Acute Opportunistic Infection: Results from ACTG A5164

REFERENCES

• Mocroft A, Lundgren JD, Sabin ML, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med. 2013;10(9):e1001510.
   PubMed Web of Science ®Google Scholar
• Harris JE. Improved short-term survival of AIDS patients initially diagnosed with Pneumocystis carinii pneumonia, 1984 through 1987. JAMA. 1990;263(3):397–401.
   PubMed Web of Science ®Google Scholar
• van der Horst CM, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. New Engl J Med. 1997;337(1):15–21.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Gilpin AM, Min YI, Erice A, Kempen JH, Quinn TC. HIV and cytomegalovirus viral load and clinical out-comes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial. AIDS (Lond). 2002 ;16(6):877–887.
   PubMed Web of Science ®Google Scholar
• Bicanic T, Brouwer AE, Meintjes G, et al. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS (Lond). 2009;23(6):701–706.
   PubMed Web of Science ®Google Scholar
• Varma JK, Nateniyom S, Akksilp S, et al. HIV care and treatment factors associated with improved survival during TB treatment in Thailand: An observational study. BMC Infect Dis. 2009;9:42.
   PubMed Web of Science ®Google Scholar
• Croda J, Croda MG, Neves A, De Sousa dos Santos S. Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit. Crit Care Med. 2009;37(5)1 605–1611.
   Web of Science ®Google Scholar
• Ravimohan S, Tamuhla N, Steenhoff AP, et al. Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiret-roviral therapy with active tuberculosis. J Infect Dis. 2013;208(11):1784–1793.
   PubMed Web of Science ®Google Scholar
• Boulware DR, Hullsiek KH, Puronen CE, et al. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associ-ated with increased risk of AIDS or death. J Infect Dis. 2011203(11):1637–1646.
   Google Scholar
• Grant PM, Komarow L, Lederman MM, et al. Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who devel-oped immune reconstitution inflammatory syndrome dur-ing ACTG A5164. J Infect Dis. 2012;206(11):1715–1723.
   PubMed Web of Science ®Google Scholar
• Kalayjian RC, Machekano RN, Rizk N, et al. Pretreat-ment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy. J Infect Dis. 2010;201(12)1 796–1805.
   Web of Science ®Google Scholar
• Zolopa A, Andersen J, Powderly W, et al. Early antiretrovi-ral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: A multicenter random-ized strategy trial. PloS One. 2009;4(5):e5575.
   PubMed Web of Science ®Google Scholar
• Armstrong-James D, Copes AJ, Walzer PD, Edwards SG, Miller RE A prognostic scoring tool for identifica-tion of patients at high and low risk of death from HIV-associated Pneumocystis firoyecii pneumonia. Int J STD AIDS. 2011;22(11):628–634.
   PubMed Web of Science ®Google Scholar
• Fanjul F, Riveiro-Barciela M, Gonzalez J, et al. Evaluation of progressive multifocal leukoencephalopathy treatments in a Spanish cohort of HIV-infected patients: Do protease inhibitors improve survival regardless of central nervous system penetration-effectiveness (CPE) score ? HIV Med. 2013;14(5):321–325.
   PubMed Web of Science ®Google Scholar
• Wachter RM, Russi MB, Bloch DA, Hopewell PC, Luce JM. Pneumocystis carinii pneumonia and respiratory failure in AIDS. Improved outcomes and increased use of intensive care units. Am Rev Respir Dis. 1991 143(2):251–256.
   PubMed Web of Science ®Google Scholar
• Walzer PD, Evans HE, Copes AJ, Edwards SG, Grant AD, Miller RE Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006. Clin Infect Dis. 2008;46(4):625–633.
   PubMed Web of Science ®Google Scholar
• Jarvis JN, Bicanic T, Loyse A, et al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: Implications for improving outcomes. Clin Infect Dis. 2014;58(5):736–745.
   PubMed Web of Science ®Google Scholar
• Bennett CL, Weinstein RA, Shapiro MF, et al. A rapid preadmission method for predicting inpatient course of disease for patients with HIV-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med. 1994; 150(6 Pt 1):1503–1507.
   PubMed Web of Science ®Google Scholar
• Blanc FX, Sok T, Laureillard D, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. New Engl J Med. 2011365(16):1471–1481.
   Google Scholar
• Levine RS, Briggs NC, Kilbourne BS, et al. Black-White mortality from HIV in the United States before and after introduction of highly active antiretroviral therapy in 1996. Am J Public Health. 2007;97(10):1884–1892.
   PubMed Web of Science ®Google Scholar
• Lemly DC, Shepherd BE, Hulgan T, et al. Race and sex differences in antiretroviral therapy use and mortal-ity among HIV-infected persons in care. J Infect Dis. 2009;199(7):991–998.
   PubMed Web of Science ®Google Scholar
• Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5(10):e203.
   PubMed Web of Science ®Google Scholar
• McDonald B, Moyo S, Gabaitiri L, et al. Persistently ele-vated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: Results from a clinical trial. AIDS Res Human Retro viruses. 2013;29(7):993–999.
   PubMed Web of Science ®Google Scholar
• Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infec-tion. J Infect Dis. 2011;203(6):780–790.
   PubMed Web of Science ®Google Scholar
• Erlandson KM, Allshouse AA, Jankowski CM, et al. Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy. J Infect Dis. 2013;208(2):249–259.
   PubMed Web of Science ®Google Scholar
• Boulware DR, Meya DB, Bergemann TL, et al. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: A prospective cohort study. PLoS Med. 2010;7(12):e1000384.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235–238.
   PubMed Web of Science ®Google Scholar
• Subramanian S, Tawakol A, Burdo TH, et al. Arterial inflammation in patients with HIV. JAMA. 2012;308(4): 379–386.
   PubMed Web of Science ®Google Scholar
• Barber DL, Andrade BB, Sereti I, Sher A. Immune reconstitution inflammatory syndrome: The trouble with immunity when you had none. Nature Rev Microbiol. 2012;10(2)1 50–156.
   Web of Science ®Google Scholar
• Brenchley JM, Price DA, Schacker TW, et al. Micro-bial translocation is a cause of systemic immune activa-tion in chronic HIV infection. Nature Med. 2006;12(12): 1365–1371.
   PubMed Web of Science ®Google Scholar
• Andrade BB, Hullsiek KH, Boulware DR, et al. Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses. J Infect Dis. 2013;207(9): 1379–1388.
   PubMed Web of Science ®Google Scholar
• Benfield TL, Vestbo J, Junge J, Nielsen TL, Jensen AB, Lundgren JD. Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am J Respir Crit Care Med. 1995;151(4):1058–1062.
   PubMed Web of Science ®Google Scholar
• Cozzi-Lepri A, French MA, Baxter J, et al. Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: Results from a large international clinical trial. AIDS (Lond). 2011;25(9)1207–1217.
   Web of Science ®Google Scholar